<--- Back to Details
First PageDocument Content
Papillomavirus / Gynaecological cancer / Ribbon symbolism / Cancer organizations / Breast cancer screening / HPV vaccine / United States Preventive Services Task Force / American Cancer Society Cancer Action Network / Cancer / Medicine / Oncology / Cancer screening
Date: 2015-03-09 13:50:13
Papillomavirus
Gynaecological cancer
Ribbon symbolism
Cancer organizations
Breast cancer screening
HPV vaccine
United States Preventive Services Task Force
American Cancer Society Cancer Action Network
Cancer
Medicine
Oncology
Cancer screening

Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky (includes kynect) for health professionals Key: ✓Covered as preventive, ⚑ Caution: may not be covered as preventive, x

Add to Reading List

Source URL: www.kycancerc.org

Download Document from Source Website

File Size: 330,60 KB

Share Document on Facebook

Similar Documents

INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect

INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect

DocID: 1rtdm - View Document

RTT / Gynaecological cancer / Gynaecology / Ovarian cancer

Elvira Ann Marano August 20, October 27, 2010

DocID: 1rpU4 - View Document

PDF Document

DocID: 1rmwK - View Document

Be Healthy  Wellness Benefits Be Healthy–

Be Healthy Wellness Benefits Be Healthy–

DocID: 1rifu - View Document

Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat

Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat

DocID: 1re0N - View Document